Folic acid and reduction of the cardiovascular risk from iperomicisteinemia in the patients subordinates to liver transplant. - ND

• Conditions: Reduction of the overomocisteinemie; MedDRA version: 9.1Level: LLTClassification code 10051286Term: Hyperhomocysteinaemia

• Registration Number: EUCTR2005-005178-55-IT
• Lead Sponsor: AZIENDA OSPEDALIERA DI BOLOGNA POLICLINICO S. ORSOLA M. MALPIGHI

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2007-03-28
• Last Update Posted: 19 March 2012

Recruitment & Eligibility

• Status: Authorised-recruitment may be ongoing or finished
• Sex: All
• Target Recruitment: Not specified

Inclusion Criteria

Patients subordinates to transplant of liver from at least 6 months with advanced levels of total plasmatic omocisteine over to 15 mmol/L, decided to accept to join voluntarily to the study.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

Patients subordinates to transplant of liver from at least 6 months that they do not accept to join to the voluntary study and patients who have one contraindication to the supplement with folic acid

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified